Publications

Export 6557 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G H I J K L [M] N O P Q R S T U V W X Y Z   [Show ALL]
M
Gheita, T. A., Y. Ezzat, S. Sayed, G. El-Mardenly, and W. Hammam, "Musculoskeletal manifestations in patients with malignant disease.", Clinical rheumatology, vol. 29, issue 2, pp. 181-8, 2010 Feb. Abstract

To detect and describe the incidence of musculoskeletal manifestations in different malignant diseases as well as their relation to the treatment received whether by chemotherapy or radiation therapy. Sixty patients with different malignant diseases were included in this study, 45 with solid tumors and 15 patients with hematological malignancy. The mean age was 46.55 +/- 11.04 years and the mean disease duration was 2 +/- 0.75 years. The patients were fully examined for any rheumatologic involvement, laboratory investigations were performed as well as dual energy X-ray absorptiometry study for bone densitometry. Treatment strategies were assessed including the chemotherapeutics, radiation therapy, and/or surgery. Myalgias and arthralgias were the most frequent followed by flexor tenosynovitis, frozen shoulder, and fibromyalgia syndrome. Hypertrophic osteoarthropathy was seen in five patients, cutaneous vasculitis in two patients as well as arthritis. Osteonecrosis was present in one of the lunate carpal bones of a patient with non-Hodgkin's lymphoma (1.67%) and receiving high dose steroids. Rheumatoid factor was positive in four patients, three of which had hepatitis C virus positivity and cryoglobulins. Anti-neutrophil cytoplasmic antibody was negative in all the studied patients. The bone mineral density was significantly reduced in the patients with malignancy compared to the control. Mild to moderate osteoporosis was present, being more evident in the spine and forearm. The bone loss was higher in those with solid tumors and even more obvious in those receiving aromatase inhibitors. Musculoskeletal manifestations occurring during malignancies and following the treatment represent a significant percentage of symptoms and signs which may raise a clue to differential diagnosis.

Gheita, T. A., Y. Ezzat, S. Sayed, G. El-Mardenly, and W. Hammam, "Musculoskeletal manifestations in patients with malignant disease.", Clinical rheumatology, vol. 29, issue 2, pp. 181-8, 2010 Feb. Abstract

To detect and describe the incidence of musculoskeletal manifestations in different malignant diseases as well as their relation to the treatment received whether by chemotherapy or radiation therapy. Sixty patients with different malignant diseases were included in this study, 45 with solid tumors and 15 patients with hematological malignancy. The mean age was 46.55 +/- 11.04 years and the mean disease duration was 2 +/- 0.75 years. The patients were fully examined for any rheumatologic involvement, laboratory investigations were performed as well as dual energy X-ray absorptiometry study for bone densitometry. Treatment strategies were assessed including the chemotherapeutics, radiation therapy, and/or surgery. Myalgias and arthralgias were the most frequent followed by flexor tenosynovitis, frozen shoulder, and fibromyalgia syndrome. Hypertrophic osteoarthropathy was seen in five patients, cutaneous vasculitis in two patients as well as arthritis. Osteonecrosis was present in one of the lunate carpal bones of a patient with non-Hodgkin's lymphoma (1.67%) and receiving high dose steroids. Rheumatoid factor was positive in four patients, three of which had hepatitis C virus positivity and cryoglobulins. Anti-neutrophil cytoplasmic antibody was negative in all the studied patients. The bone mineral density was significantly reduced in the patients with malignancy compared to the control. Mild to moderate osteoporosis was present, being more evident in the spine and forearm. The bone loss was higher in those with solid tumors and even more obvious in those receiving aromatase inhibitors. Musculoskeletal manifestations occurring during malignancies and following the treatment represent a significant percentage of symptoms and signs which may raise a clue to differential diagnosis.

Ragab, G., H. El-Gendy, and R. M. El-Gohary, Musculoskeletal Disorders and Treatment, , 2017. Abstract
n/a
Awad, M. A., P. D. H. A. Sami, and D. N. Abdel-Razek, Musculoskeletal application of multislice CT, , cairo, cairo, 2006.
Kotb, M. A., and H. A. K. Abdalla, "Musculoskeletal and neurological affection associated with neonatal and infantile cholestasis: Review of a historical cohort (1985-2005). ", The Egyptian Rheumatologist , vol. 29, issue 1, pp. 475-489, 2007.
Soheir M Abd El Rahman, P. D., and A. A. Hagag, "Muscular and Hormonal responses to whole body vibration exercises in eldery", World applied sciences journal, vol. 32, issue 9, pp. 1775-1779, 2014.
undefined, and A. A. Hagag, "Muscular and Hormonal Responses to Whole Body Vibration Exercises in Elderly", World Applied Sciences Journal, vol. 32, issue 9, pp. 1775-1779, 2014.
, "Muscle-Invasive Bladder Cancer in Egypt: Pathologic Considerations Based on a Series of 581 Radical Cystectomies:", Medical Journal of Cairo University, vol. 79, issue 1, pp. 313-315, 2011.
Youssef, A. R., S. R, L. T, and W. Herzog, "Muscle Weakness Causes Joint Degenration in Rabbits", Osteoarthritis Cartilage, vol. 17, pp. 1228-35, 2009.
Youssef, A. R., S. R, L. T, and W. Herzog, "Muscle Weakness Causes Joint Degenration in Rabbits", The 16th Congress of the European Society of Biomechanics, Lucerne, Switzerland, 2008.
Youssef, A. R., S. R, L. T, and W. Herzog, "Muscle Weakness Causes Joint Degenration in Rabbits", The 54th annual meeting of the Orthopaedic Research Society, San francisco, USA, 2008.
Youssef, A. R., S. R, L. T, and W. Herzog, "Muscle weakness Causes Joint Degenration in Rabbits", Proceedings of the 8th Alberta Biomedical Engineering conference, Banff, Alberta, Canada, 2007.
Moubarez, D. A., K. A. E. A. Mohamed, S. S. E. Din, M. A. Basheer, and A. A. E. - R. E. Baz, "Muscle ultrasound in assessment of critical illness neuromyopathy in comparison with nerve conduction", journal of advanced pharmacy education and research, vol. 19-1, pp. 2249-3379, 2019. doaapdf.pdf
A, K., A. R. Youssef, A. KA, and H. GA, "Muscle Recovery with Exercise During Distraction Osteogenesis", 9th International Deformity Correction Conference, Mena House Oberoi Hotel, Cairo, Egypt, 2013.
L., K. A., A. F. H., O. K. A., R. E., and A. O. R., "Muscle Inhibitory Vs Functional Corrective Kinesio Taping on Gross Motor Functional Abilities in Children with Spastic Cerebral Palsy.", Journal of Complementary and Alternative Medical Research, vol. 6, issue 1, 2018.
Kora, A. N., F. H. Abdelazeim, K. A. Olama, E. A. R. Raouf, and O. R. Abdelraouf, "Muscle Inhibitory Vs Functional Corrective Kinesio Taping on Gross Motor Functional Abilities in Children with Spastic Cerebral Palsy", Journal of Complementary and Alternative Medical Research, vol. 6, issue 1, pp. 1-9, 2018. Abstractkora612018jocamr42637.pdf

Background and Purpose: Spastic cerebral palsy affects ankle joint function leading to a
decrease of the gross motor functional abilities. The purpose of the study was to compare the
Muscle inhibitory with Functional corrective Kinesio Taping applications on gross motor functional
abilities of children with spastic cerebral palsy.
Methods: Thirty-two children with spastic cerebral palsy were selected from the outpatient clinic of
the faculty of Physical Therapy Cairo University. Muscle inhibitory and functional corrective Kinesio
taping applications in addition to physical therapy program were applied for three successive
months. Peabody Developmental Motor Scales was used to assess the gross motor functional
abilities.
Results: The study revealed that statistically and clinically there was no difference between both
applications.
Conclusion: Muscle inhibitory and Functional Corrective Kinesio Taping applications both can be
used for increasing the gross motor functional abilities of children with spastic cerebral palsy with
no favour to any of them.

Elhafez, S. M., A. A. Ashour, N. M. Elhafez, and G. M. Elhafez, "Muscle Contribution to Supporting Phase During Normal Speed of Walking", World Confederation for Physical Therapy (WCPT), Suntec City, Singapore, 2 May, 2015. muscle_contribution.docx
Tourism